This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Understand why making regular budget adjustments is crucial for maintaining financial health. It helps you stay on track.
21,254 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
AI-driven momentum is sweeping through workplaces and markets, yet the official data trail remains far behind. Econom...
Beijing and Hong Kong unveiled a coordinated package to deepen offshore yuan liquidity and gold settlement, signaling...
Meta and Microsoft posted strong results, yet insider selling patterns diverged sharply. Meta's executives have been ...
After the latest earnings, investors are weighing growth prospects, margins, and valuation for Domino's. This guide b...
Curious if you can win the lottery of Social Security—that $5,251-a-month top payout in 2026? It hinges on work credi...
In the wake of a Supreme Court ruling voiding emergency tariffs, Trump warns trading partners they could face far har...
We unpack the Q4 results and what ftai (fip) 2025 earnings imply for the year ahead. Learn the key drivers, risk fact...
OpenAI unveils GPT-5.4, its most capable enterprise AI to date, combining advanced reasoning, coding, and autonomous ...
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
Investors are weighing Oklo's unique nuclear energy model against a bumpy ride in its stock. This guide breaks down t...
Western Midstream Partners raised its quarterly distribution to $0.93 per unit, pushing the annualized payout to $3.7...